Sign up for Table of Contents Alerts.
Email this page
Print this page
Commentary
Survivin: The promising target in hepatocellular carcinoma gene therapy
Jie Liu, Wenqi Du and Daiming Fan
volume 7 | issue 4
April 2008Pages: 555 - 556
Subscribe to this journal for $129/year
Commentary to:
Rui Zhang, Tao Wang, Kai-Nan Li, Wei-Wei Qin, Rui Chen, Kai Wang, Lin-Tao Jia, Jing Zhao, Wei-Hong Wen, Yan-Ling Meng, Li-Bo Yao and An-Gang Yang
Authors
Jie Liu
State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China
Wenqi Du
State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China
Daiming Fan
State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China





